For: | Chen WM, Chen WD, Jiang XM, Jia XF, Wang HM, Zhang QJ, Shu YQ, Zhao HB. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. World J Gastroenterol 2017; 23(33): 6100-6110 [PMID: 28970725 DOI: 10.3748/wjg.v23.i33.6100] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i33/6100.htm |
Number | Citing Articles |
1 |
Yutong Sun, Li Ma. New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis. Cancers 2019; 11(2): 216 doi: 10.3390/cancers11020216
|
2 |
Yinghui Yu, Yinlong Zhao, Chunpeng Wang, Xueyuan Zhang, Xin Liu. Long noncoding RNAs as diagnostic biomarkers for the early detection of digestive tract cancers: a systematic review and meta-analysis. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.5450/2018
|
3 |
Wencheng Kong, Guang Yin, Sixin Zheng, Xinchun Liu, Akao Zhu, Panpan Yu, Jian Zhang, Yuqiang Shan, Rongchao Ying, Huicheng Jin. Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer. Genes & Diseases 2022; 9(5): 1269 doi: 10.1016/j.gendis.2021.07.006
|
4 |
Hossein Mohebbi, Romina Esbati, Ran Abdalsalam Hamid, Roozbeh Akhavanfar, Usama Kadem Radi, Goli Siri, Omid Yazdani. EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09237-7
|
5 |
Mehrdad Hashemi, Naghmeh Nazdari, Ghazaleh Gholamiyan, Mahshid Deldar Abad Paskeh, Ali Moghadas Jafari, Fateme Nemati, Elaheh Khodaei, Ghazal Abyari, Nazanin behdadfar, Behnaz Raei, Rasoul Raesi, Noushin Nabavi, Peng Hu, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari. EZH2 as a potential therapeutic target for gastrointestinal cancers. Pathology - Research and Practice 2024; 253: 154988 doi: 10.1016/j.prp.2023.154988
|
6 |
Huichen Zhao, Huihui Hu, Beibei Chen, Weifeng Xu, Jing Zhao, Chen Huang, Yishu Xing, Huifang Lv, Caiyun Nie, Jianzheng Wang, Yunduan He, Sai-Qi Wang, Xiao-Bing Chen. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.689139
|
7 |
Soudeh Ghafouri-Fard, Sepideh Dashti, Molood Farsi, Mohammad Taheri. HOX transcript antisense RNA: An oncogenic lncRNA in diverse malignancies. Experimental and Molecular Pathology 2021; 118: 104578 doi: 10.1016/j.yexmp.2020.104578
|
8 |
Halil Ibrahim Toy, Didem Okmen, Panagiota I. Kontou, Alexandros G. Georgakilas, Athanasia Pavlopoulou. HOTAIR as a Prognostic Predictor for Diverse Human Cancers: A Meta- and Bioinformatics Analysis. Cancers 2019; 11(6): 778 doi: 10.3390/cancers11060778
|
9 |
Diaa Al-Raawi, Aditi Kanhere. Autoregulation of JARID2 through PRC2 interaction with its antisense ncRNA. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-05348-z
|
10 |
Vytenis Petkevicius, Cosima Thon, Ruta Steponaitiene, Jurgita Skieceviciene, Dainius Janciauskas, Doerthe Jechorek, Peter Malfertheiner, Juozas Kupcinskas, Alexander Link. Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer. Clinical and Translational Gastroenterology 2022; 13(5): e00483 doi: 10.14309/ctg.0000000000000483
|
11 |
Yan Lu, Kaiqing Hou, Mengsen Li, Xiaobin Wu, Shaochun Yuan. RETRACTED: Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.571297
|
12 |
Hui Wang, Rong Qin, Aoran Guan, Ying Yao, Yun Huang, Hongping Jia, Weikang Huang, Jianpeng Gao. HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR‐217 expression. Journal of Cellular Biochemistry 2018; 119(9): 7226 doi: 10.1002/jcb.26901
|
13 |
Yun Zhang, Yu Zhou, Tian Xu, Wei Tian, Chong Yang, Xiaoxiao Wang, Shan Zhong, Qin Ran, Hongji Yang, Shikai Zhu. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618756783
|
14 |
Linda Vidarsdottir, Rita Valador Fernandes, Vasilios Zachariadis, Ishani Das, Elin Edsbäcker, Ingibjorg Sigvaldadottir, Alireza Azimi, Veronica Höiom, Johan Hansson, Dan Grandér, Suzanne Egyházi Brage, Katja Pokrovskaja Tamm. Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib. Melanoma Research 2020; 30(5): 443 doi: 10.1097/CMR.0000000000000675
|
15 |
Dejun Yang, Mengyao Shi, Qing You, Yu Zhang, Zunqi Hu, Jiapeng Xu, Qingping Cai, Zhenxin Zhu. Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and EZH2-mediated p53 repression in gastric cancer. Cell Biology and Toxicology 2023; 39(4): 1341 doi: 10.1007/s10565-022-09760-y
|
16 |
Plabon Kumar Das, Saharia Yeasmin Asha, Ichiro Abe, Farhadul Islam, Alfred K. Lam. Roles of Non-Coding RNAs on Anaplastic Thyroid Carcinomas. Cancers 2020; 12(11): 3159 doi: 10.3390/cancers12113159
|
17 |
Hang Yu, Long Rong. Emerging role of long non-coding RNA in the development of gastric cancer. World Journal of Gastrointestinal Oncology 2018; 10(9): 260-270 doi: 10.4251/wjgo.v10.i9.260
|
18 |
Boheng Li, Wee-Joo Chng. EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0814-6
|
19 |
Maryam Sabour‐Takanlou, Leila Sabour‐Takanlou, Cigir Biray‐Avci. EZH2‐associated tumor malignancy: A prominent target for cancer treatment. Clinical Genetics 2024; 106(4): 377 doi: 10.1111/cge.14576
|
20 |
Chang‐Jin Fu, Jing Cong, Shan‐Shan Sun, Meng‐Meng Ren, Shu‐Yang Xie, Ping‐Yu Wang. Diagnostic roles of HOX transcript antisense intergenic RNA in cancer. Asia-Pacific Journal of Clinical Oncology 2021; 17(2) doi: 10.1111/ajco.13300
|